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ABSTRACT 
 
Development of a Blood Flow Measurement Protocol Using Particle Image Velocimetry 
 
Jennifer Chi-Ying Go 
 
 
 Peripheral Arterial Occlusive Disease (PAOD) is an acquired inflammatory disease 
where a peripheral artery becomes occluded due to the buildup of atherosclerotic plaques. In 
patients that possess collateral arteries, an occlusion can lead to shear induced outward 
remodeling, arteriogenesis, of these collaterals, partially restoring blood flow. However, newly 
remodeled collaterals exhibit reduced functional vasodilation, which may impair normal activity, 
such as ambulation. To model chronic ischemia and arteriogenesis in collaterals, a femoral artery 
ligation in a murine hindlimb is commonly performed. Previous efforts by our group involved 
measurements of collateral artery diameter to assess the impact of arteriogenesis on functional 
vasodilation/vascular reactivity; however diameter measurements are not as descriptive as an 
assessment of flow, and performing particle image velocimetry allows the change in blood flow 
control to be investigated. Particle image velocimetry was performed in the profunda femoris 
artery of unoperated murine hindlimbs with 3µm fluorescent microspheres. Resting and 
vasodilation measurements were assessed for protocol validation. As expected, muscle 
stimulation increased flow significantly compared to that assessed at resting, accordingly, all 
other measured parameters also increased significantly.   
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Chapter 1: INTRODUCTION  
 
Atherogenesis  
 Atherogenesis is the buildup of atherosclerotic plaques along the walls of an artery [1] 
(Figure 1). Turbulent shear, at artery branch points, along with concurrent factors, place an 
individual at an increased risk of this disease.  
 
 
Figure 1: Progression of Atherosclerosis. Progression of atherosclerosis, which eventually 
leads to occlusion, in a blood vessel [2]. 
Endothelial cells which line the luminal surface of an artery become activated by 
turbulent shear, causing them to contract from one another, display adhesion proteins on their 
surface, and secrete chemokines that attract passing monocytes. Through integrin/adhesion 
protein binding, monocytes bind to the endothelial cell and eventually extravasate into the 
subendothelial space, becoming macrophages. Low density lipoproteins (LDLs) also extravasate 
from the blood stream into the subendothelial space where they react with superoxide released by 
macrophages and become oxidized LDL. Oxidized LDL further activates the endothelium and is 
also recognized by macrophages and endocytosed. As a result, macrophages filled with oxidized 
LDL become lipid-laden foam cells.    
 When a macrophage endocytoses oxidized LDL, antigen processing and presentation 
occur.  T-helper cells recognize the oxidized LDL antigen presented on the surface of the 
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macrophage and release interferon gamma (INF γ), INF γ further activates the endothelial cells 
and macrophages. Activated macrophages release pro-inflammatory cytokines such as tumor 
necrosis factor alpha (TNF-α), mucosinoids, proteases, and coagulation factors. TNF-α leads to 
the proliferation and migration of smooth muscle cells (SMCs), and further activates the 
endothelium; mucosinoids induce vasospasm in SMCs, proteases disrupt forming plaques by 
ruptruing the endothelial layer, and coagulation factors released into the blood stream cause 
thrombosis. 
All the aforementioned factors contribute to the build-up of atherosclerotic plaques in the 
subendothelial space and the occlusion of an artery. Unfortunately, if nothing impedes the 
atherogenic process, a condition that can be likened to that of a positive feedback loop, once the 
disease begins it will progress and become exacerbated.   
 
Peripheral Arterial Occlusive Disease 
 Peripheral Arterial Occlusive Disease, commonly referred to as PAOD, is an acquired 
inflammatory disease where a peripheral artery becomes occluded due to the buildup of 
atherosclerotic plaques. In patients, PAOD generally manifests itself in the femoral artery which 
becomes progressively occluded, and blood flow to the lower region of the limb is significantly 
decreased [3] (Figure 2). In the United States, approximately 8 million individuals suffer from 
PAOD, including approximately 12-20% of individuals over 60 years of age [3]. 
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Figure 2: Peripheral Arterial Occlusive Disease (PAOD). PAOD is the buildup of 
atherosclerotic plaques in the peripheral circulation, such as in the leg [4]. 
 In many individuals, PAOD may be asymptomatic, however it is common for PAOD 
patients to experience intermittent claudication, ischemic leg pain, while walking or exercising. 
In extreme cases of PAOD, patients with critical limb ischemia experience pain during rest. 
Furthermore individuals with PAOD have an increased risk of developing cerebrovascular or 
coronary artery disease, which may lead to stroke or a heart attack respectively [5].  
 The occurrence of PAOD increases with age in both men and women and is more 
common in African Americans, Non-Whites, Hispanics, and Asians [6]. Risk factors of 
symptomatic ischemic disease include a high cholesterol diet, increased LDL in the blood 
stream, and influences that damage the endothelial lining such as hypertension, diabetes, and 
smoking.    
 If PAOD is left untreated and the vessel continues to occlude to the point where little or 
no flow is present, the tissue downstream of the occlusion can become ischemic, i.e. flow is not 
sufficient to support metabolic demands [7]. If ischemia worsens to the point of tissue necrosis, it 
is possible that the limb may be amputated; however in many cases a patient will experience 
cardiac failure (i.e. myocardial infarction) subsequent to the necessity of limb loss [8].   
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Treatment for Peripheral Arterial Disease 
 Depending on the severity of the disease, patients with PAOD are encouraged to exercise, 
stop smoking, and assume a healthier diet. However, in serious cases of PAOD, where the 
disease has become significantly exacerbated, lifestyle changes are insufficient and some form of 
pharmacological, endovascular, or surgical intervention is required. Pharmacotherapy is typically 
administered first since it is a less invasive treatment.     
Pharmacotherapy can be used to treat PAOD by delivering pharmacological agents to 
target the inflammatory process and progression of atherogenesis or to prevent thrombus 
formation.  Angiotensin converting enzyme (ACE) inhibitors are typically prescribed to patients 
as a means to alleviate hypertension and in turn decrease the endothelial activation that triggers 
atherogenesis [9].  Antiplatelet drugs, i.e. aspirin, are also prescribed to decrease the likelihood 
of thrombus formation that would completely occlude a narrow vessel [10].   
Endovascular intervention involves insertion of a balloon catheter to the area of the 
blockage which is then expanded to clear the blockage (Figure 3). To ensure patency of the 
vessel post-angioplasty, a stent is typically threaded around the balloon catheter and when 
inflated the stent is expanded against the inside of the vessel to support the walls [11]. A surgical 
technique commonly used to treat PAOD is bypass grafting, where a vessel is harvested from 
another area of the body and grafted around the blockage, diverting flow past the blockage and 
resuming relatively normal blood flow.   
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Figure 3: Endovascular Intervention. Steps involved in an endovascular intervention [12]. A – 
A balloon catheter with a stent threaded on the end is guided to the site of the blockage. B – 
Balloon is expanded, deploying the stent, keeping it in place. C – Balloon is deflated and catheter 
is removed, normal blood flow is restored.  
 In patients, a host of problems may be present in addition to PAOD, and the delivery of 
pharmacological agents may not be sufficient in effectively treating their condition.  This 
necessitates the use of endovascular or surgical interventions, however endovascular treatments 
are not always permanent and may result in the re-occlusion of an artery [8].  Surgical 
intervention is typically highly invasive and may lead to multiple post-operative complications, 
such as prolonged healing. For these reasons promoting endogenous therapeutic 
revascularization is a common area of investigation.      
 
Microcirculation and Peripheral Arterial Occlusive Disease 
 As mentioned previously, the peripheral arterial occlusion prevents an adequate supply of 
oxygenated blood from reaching the downstream vasculature, which leads to ischemia of the 
limb. Even if no interventions are used to treat the occlusion in a patient with PAOD, the 
vasculature will adapt to the modified hemodynamics, by attempting to normalize shear stresses, 
and these adaptations will partially restore blood supply to a given region.   
6 
 
 When an occlusion is present in a vessel, blood will be directed through natural bypass 
routes, termed collateral networks.  This redirection in flow increases blood flow and shear 
stresses through these collateral vessels, stimulating arteriogenesis, or the outward remodeling, 
of these collateral vessels (Figure 4). 
 
 
Figure 4: Arteriogenesis. The progression of arteriogenesis, outward remodeling of a collateral 
vessel in response to increased shear stress [13].  
 This increase in shear stress activates the endothelial cells (ECs) which line the luminal 
surface, causing them to contract from one another, display adhesion proteins on their surface, 
and secrete chemokines that attract passing monocytes. Through integrin/adhesion protein 
binding, monocytes bind to the endothelial cell and eventually extravasate into the 
subendothelial space becoming macrophages. These macrophages subsequently secrete 
matrixmetalloproteinases (MMPs). Also secreted by ECs are vascular endothelial growth factor 
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(VEGF), and tumor necrosis factor-α (TNF-α).  MMPs degrade the pre-existing matrix to allow 
for collateral enlargement, VEGF causes EC proliferation, and TNF-α causes smooth muscle cell 
(SMC) proliferation.  Fibroblasts, present in the perivascular space, together with the new ECs 
and SMCs form a new matrix.  This process occurs until the collateral vessel has enlarged to the 
point where shear stresses have been normalized.   
 Since arteriogenesis is an endogenous form of therapeutic revascularization, investigators 
are interested in studying this process for the purposes of a potential clinical treatment for those 
suffering with PAOD or other types of occlusive diseases. Chronic ischemia and arteriogenesis 
can be simulated by an arterial occlusion surgery and studied in a murine animal model.  
Following ligation of the femoral artery in the murine hindlimb, blood flow is directed 
through the profunda femoris artery, through the network of vessels in the gracilis muscles, and 
through the saphenous artery to perfuse the hindlimb (Figure 5). At seven days post ligation 
enlargement of the profunda femoris artery is pronounced and can be studied. Currently, this 
remodeling is assessed by directly measuring the diameter of the profunda femoris artery in a 
femoral artery ligated hindlimb and comparing to that of a non-ligated hindlimb. Vascular 
reactivity is assessed through functional vasodilation, stimulating a muscle that is directly fed by 
the remodeled vessel. However, at seven days post ligation the outwardly remodeled vessel 
exhibits decreased vasodilation. To account for this decreased vasodilation, two differing 
mechanisms have been hypothesized- mechanoadaptation and endothelial cell dysfunction. 
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Figure 5: Collateral Network in Mouse Hindlimb. Vascular network in the mouse hindlimb.  
 
Sources of Dysfunctional Vasoreactivity 
 In response to constant vasodilatory or vasoconstrictory stresses, the smooth muscle cells 
(SMCs) in the vascular wall will reposition themselves to normalize these stresses in a 
mechanism referred to as mechanoadaptation [14]. During mechanoadaptation SMCs will 
rearrange their attachment to other SMCs as well as other surrounding cells in the extracellular 
matrix (ECM) [15]. When mechanoadaptive enlargement occurs, it is hypothesized that the 
rearrangement of SMCs may impair their ability to relax and produce vasodilation.   
 Endothelial dysfunction is a second possible explanation for reduced vasoreactivity. 
Under normal circumstances, in response to increased shear and receptor-dependent dilators, 
endothelial cells (ECs) release nitric oxide (NO) which induces vasodilation of the vessel 
(Figure 6). However during inflammation, NADPH oxidase is activated by chemokines, leading 
to the production of superoxide which deactivates NO and thus hinders endothelial dependent 
vasodilation.   
 
Profunda femoris a. 
Profunda femoris v. Saphenous a. 
Saphenous 
v.
Popliteal 
branch 
Ligation site
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Figure 6: Normal Vasodilatory Mechanisms. Normal smooth muscle cell and endothelial cell 
dependent vasodilation [16].  
 If a patient with PAOD is capable of therapeutic revascularization, a reduced ability to 
vasodilate, and thus control flow, in outwardly remodeled vessels is problematic because the 
delivery of a sufficient amount of oxygenated blood is contingent upon proper vasoreactivity in 
the collateral vessel. In order to analyze flow in a vessel, diameter measurements are not 
adequate on their own and must be paired with velocity measurements to calculate flow. To 
measure velocity in a given vessel a particle image velocimetry protocol was developed.    
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Chapter 2: PARTICLE IMAGE VELOCIMETRY  
Protocol Development 
As mentioned earlier, prior to the development of this protocol, measurement of vessel 
diameter was the only descriptive indicator depicting vascular changes. With the implementation 
of particle image velocimetry another aspect of vascular remodeling can be measured, flow.  
Flow measurements are an important aspect of vascular remodeling because it allows for direct 
observation of changes in flow control, diameter measurements can only communicate so much 
from which the rest of the information, like changes in velocity, must be indirectly inferred.   
 Collateral networks consist of three zones, (Figure 7): the stem, midzone, and reentry, 
through which blood flows to re-perfuse the hindlimb. The stem region, profunda femoris artery, 
was selected for developing the Particle Image Velocimetry Protocol because of its superficial 
position; however particle image velocimetry is applicable to other regions of the mouse 
circulatory system.  
 
 
Figure 7: Zones of Collateral Network in Mouse Hindlimb. Three zones of the collateral 
network in the mouse hindlimb:  the stem, midzone, and reentry. 
 
Preexisting Methods 
 There are many methods to measure blood velocity/flow including Doppler ultrasound, 
Side-Stream Dark-Field Microscopy, and Fluorescence Recovery After Photobleaching (FRAP). 
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Below is an explanation of these approaches and reasons describing why they are not appropriate 
for this application of particle image velocimetry.  
 Doppler ultrasound is commonly used for measuring blood flow in mice, and can be used 
in large vessels, such as the ascending aorta of mice [17]. Doppler ultrasound involves the 
emission of high frequency sound waves (2-18 MHz) which are reflected from blood and excite 
the detector, moving fluid will result in different reflective frequencies and excite the detector 
differently. Doppler ultrasound is non-invasive and relatively easy to perform, however in order 
to obtain a unit that is small enough to use in a murine animal model it becomes increasingly 
expensive and thus is not as practical; additionally vessels smaller than that of a murine femoral 
artery may not be imaged properly. The largest caveat of Doppler ultrasound is its resolution, the 
ability to discern two points from one another, and in a small structure such as a murine blood 
vessel this drawback becomes an increasingly important concern [18]. If two points are too close 
together this may be detected as a single artifact by the detector and lead to an inaccurate 
reading; especially when blood in a vessel differs widely, depending on the location within the 
vessel (middle or edge) accuracy is of utmost importance.   
 Currently, Side-Stream Dark-Field (SDF) Microscopy is used to image the diameter of 
vessels as well as measure velocity in very small vessels, i.e. capillaries. SDF Microscopy 
implements a concentric ring of LEDs emitting a wavelength of 530 nm that is the specific to the 
absorbance of hemoglobin in erythrocytes. This creates a contrasting image where the vessels 
appear dark and the surrounding tissue appears lighter.    
 Figure 
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finite number of times before its electrons undergo oxidation reactions and no longer fluoresce; 
this process is referred to as photobleaching. To perform FRAP, a region is photobleached and 
the time it takes for fluorescent particles to return to the area is tracked. In addition to volumetric 
flow, FRAP can be used to monitor the diffusive properties in a region of interest [19]. This 
technique is elegant and provides other benefits such as the ability to image deeper into tissue, 
less auto-fluorescence from the surrounding tissue, and increased resolution; all relative to 
widefield microscopy. However, these benefits stem from the fact that as a requirement to 
perform FRAP a confocal microscope which implements lasers and is one of the more expensive 
microscopes, must be used. Thus this method is quite complex and the intensity from the lasers 
can actually damage living tissue.  
 Taking into consideration the previously discussed methods it was evident that widefield 
microscopy while using particle image velocimetry (PIV) would be the best approach.  
Project Rationale  
 In a study performed by Al-Khazraji et al., streak lengths of fluorescent red blood cells 
(RBCs) were measured in rat skeletal muscle arterioles [20]. RBCs were fluorescently labeled 
and recirculated; a fluorescent microscope, with an attached camera, positioned over desired 
arterioles in skeletal muscle captured passing RBCs. From these images, streak lengths of 
fluorescent RBCs were clearly distinguishable and measured, shutter speed of the camera 
allowed for velocity to be calculated by dividing the streak length by camera shutter speed. This 
work demonstrated that blood velocity, in small vessels, could be measured via particle image 
velocimetry (PIV). Instead of performing RBC labeling, this Particle Image Velocimetry (PIV) 
protocol utilizes circulating fluorescent microspheres of uniform size.   
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Project Objective: Develop a Particle Image Velocimetry Protocol to measure blood 
velocity and calculate blood flow, in measured mouse skeletal muscle feed artery.  
The purpose of this objective is to establish a procedure that allows investigators to 
determine the impact of vascular remodeling on blood flow control.    
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Chapter 3: METHODS 
Animal Housing and Care 
 Male C57Bl/6 mice between 7 and 9 weeks of age were used for all experiments 
according to protocols approved by the Cal Poly State University Institutional Animal Care and 
Use Committee. Mice were housed in the University Vivarium in micro-isolator cages within a 
temperature controlled room on a 12 hour light-dark cycle. Mice were monitored daily and 
standard chow and water were provided ad libitum in addition to enrichment (cage bedding, 
mouse house, and tunnel tube).  
Mouse Preparation 
 Mice were anesthetized in an induction chamber using 3% vaporized isoflurane in 
oxygen, flowing at 0.8-1.0 1∙ min-`1. Subsequent to initial anesthetization, mice were maintained 
in a plane of anesthesia using 1-2% isoflurane in oxygen flowing at 0.8-1.0 1∙ min-`1. Mice were 
then weighed and moved to a preparatory bench for hair removal. Hair clippers and depilatory 
cream were used to remove hindlimb hair to just above the abdominal wall. Mice were 
transferred to a heat pad on the surgical bench where they were maintained at a core body 
temperature of 35°C, detected through a rectal thermistor probe for the duration of the procedure.  
Microsphere Preparation 
 Green fluorescent microspheres, 3µm in diameter (Fischer Scientific) were prepared by 
vortexing for 30sec, sonication for 5min, and vortexing once more for 30sec.  
Hindlimb Microdissection 
 An incision was made in the medial aspect of the mouse hindlimb. Blunt dissection of the 
surrounding connective tissue and adipose tissue was used to maximize exposure of the profunda 
femoris artery and vein. Perfusion of the exposed area with phosphate buffered solution (PBS) 
was performed periodically to prevent desiccation. The neurovascular bundle, which feeds the 
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epigastric fat pad, was cauterized and the entire fat pad was resected to maximize visibility. 
Careful blunt dissection was performed over the gracilis muscle to remove any overlying 
connective tissue, which minimizes the resistance to current flow and maximizes the skeletal 
muscle contraction.  
Functional Vasodilation and Microsphere Injection 
 Two tungsten microelectrodes were placed on the gracilis muscle, one stimulating and 
one ground. To ensure correct placement of electrodes, a series of stimulating contractions were 
delivered with 1mA square waves, 200µs in duration, and a frequency of 1Hz. The area was 
perfused with saline and covered with plastic wrap to prevent desiccation and oxygen transport. 
A 30-minute equilibration period allowed for the profunda femoris artery to return to resting 
diameter 
 During the equilibration period, a skin incision was made in the neck and enlarged to 
expose the jugular vein. Blunt dissection of surrounding connective tissue and adipose allowed 
for maximum exposure of the external jugular vein, through which fluorescent microspheres 
were injected.  
 An intravital fluorescent microscope, equipped with a green filter, was positioned over 
the distal profunda femoris. After the equilibration period, at resting, a series of images were 
captured of the profunda femoris artery to measure the diameter and passing microsphere streak 
length; a 5x objective and Infinity software were used. Muscle stimulation was delivered for 
90sec with 1mA square waves, 200µs in duration, at a frequency of 8Hz. Immediately following 
stimulus cessation a series of images were captured of the profunda femoris artery. Images were 
captured every minute until the diameter had returned to normal. Following the completion of 
the experiment, mice were euthanized via cervical dislocation.  
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Data and Statistical Analysis 
 ImageJ analysis software was used to measure vessel diameter and microsphere streak 
length. Microsoft Excel was used to perform statistical analysis. A p<0.05 was used to denote 
significance from a paired T-test. The following formulas were used to calculate velocity based 
on streak length and flow based on velocity, with the assumption that the artery was a perfect 
cylinder: 
 
Equation 1: Calculating Velocity 
 
ݒ݈݁݋ܿ݅ݐݕ ሾμm/sሿ ൌ
݀݅ݏݐܽ݊ܿ݁ ሾμmሿ
ݐ݅݉݁ ሾsሿ
 
 
Equation 2: Calculating Flow Through a Cylindrical Vessel 
 
݂݈݋ݓ ሾμmଷ/sሿ ൌ ܿݎ݋ݏݏ ݏ݁ܿݐ݅݋݈݊ܽ ܽݎ݁ܽሾμmଶሿ כ ݒ݈݁݋ܿ݅ݐݕሾμm/sሿ 
 
 
 Where: 
• Distance[µm]  = microsphere streak length 
• Time [s] = camera shutter speed 
• Area [µm2]  = calculated from the diameter of the vessel 
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Chapter 4: RESULTS 
 The motivation behind performing particle image velocimetry in the profunda femoris 
artery was to assess the hemodynamic changes at rest and following muscle contraction. Data 
obtained from functional vasodilation and intravital microscopy is presented below, microsphere 
streak length and vessel diameter were directly measured, from which velocity and flow were 
calculated. As expected, post-stimulation measurements of diameter, velocity, and flow were 
significantly (p<0.05) greater than at rest.   
 
Diameter 
 As expected based on previous work, gracilis muscle contraction significantly increased 
profunda femoris artery diameter, resting 56 µm ± 5 µm versus stimulated  86 µm ± 5 µm, 
p<0.05. This percent change of approximately 54% supports previous functional vasodilation 
findings where stimulation of the gracilis muscle leads to a functional vasodilation response in 
the profunda femoris.  
 
 
Figure 9: Profunda Femoris Diameter. Diameter of the profunda femoris artery post-
stimulation was significantly larger than at rest (p<0.05) (n=4).    
 
 
*
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Blood Velocity 
To calculate blood flow through the profunda femoris artery, vessel diameter and blood 
velocity are needed. Blood velocity was calculated using microsphere streak length and shutter 
speed. As expected, gracilis muscle contraction significantly increased microsphere streak 
length, resting 267 µm ± 27 µm versus stimulated  525 µm ± 53 µm, p<0.05; with a percent 
change of approximately 96%. Additionally, gracilis muscle contraction significantly increased 
blood velocity, resting 4814 µm·s-1 ± 1094 µm·s-1 versus stimulated 9163µm·s-1 ± 1732 µm·s-1, 
p<0.05; with a percent change of approximately 89%. 
 
Figure 10: Visual Depiction of Post Stimulation Changes. A – Displays the profunda femoris 
(vessel on the left) pre stimulation and the red arrow is pointing to a microsphere and its streak 
length.  B – Displays the profunda femoris post stimulation, as seen, the microsphere now has a 
longer streak length.  C – Displays the profunda femoris post stimulation, as seen, there is an 
increased presence of microspheres in this region of interest. 
 
 
 
 
 
 
 
 
 
A B C
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Figure 11: Streak Length of Microspheres in the Profunda Femoris. Streak length of 
microspheres in the profunda femoris artery post-simulation was significantly longer than at rest 
(p<0.05) (n=5).  
 
 
 
 
Figure 12: Blood Velocity in the Profunda Femoris. Blood velocity in the profunda femoris 
artery post stimulation was significantly faster than at rest (p<0.05) (n=5). 
 
Blood Flow 
 Blood flow was calculated from cross sectional area and blood velocity. As expected, 
gracilis muscle contraction significantly increased blood flow, resting 1.3E-05 mL·s-1 ± 3.9E-06 
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mL·s-1 versus stimulated 5.6E-05 mL·s-1 ± 1.0E-05 mL·s-1, p<0.05; with a percent change of 
approximately 96%. 
 
 
 
Figure 13: Blood Flow in the Profunda Femoris. Blood flow in the profunda femoris artery 
post stimulation was significantly faster than at rest (p<0.05) (n=4).  
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Chapter 5: DISCUSSION 
 Investigating peripheral arterial occlusive disease (PAOD) by modeling chronic ischemia 
via femoral artery ligation in the mouse hindlimb can be assessed by diameter measurements. 
However, to gain further insight into the vascular remodeling that occurs, blood flow 
measurements in a vessel necessary to determine the impact of vascular remodeling on blood 
flow control. A particle image velocimetry (PIV) protocol, utilizing circulating fluorescent 
microspheres, was developed as a means to calculate blood flow. 
 The efficacy of the blood flow protocol was determined by comparing results obtained at 
resting to those post stimulation of the gracilis muscle. As expected, measurements post-
stimulation were significantly (p<0.05) greater from those taken at rest for diameter, velocity, 
and flow. Functionally stimulating a given muscle simulates muscle exercise, where exercising 
muscle requires increased blood flow to meet metabolic demand, i.e. nutrient delivery and waste 
removal; thus when the gracilis muscle contracts, its feed artery, the profunda femoris artery, 
dilates and with this dilation comes increased blood velocity and flow, which was observed. 
Limitations 
 The PIV protocol also has limitations. The protocol is applied assuming the profunda 
femoris is a perfect straight cylinder, however there is slight variability within mouse vasculature 
in a sense that some profunda arteries tend to curve somewhat; to account for the curved nature 
of the microsphere streaks, the segmented line tool is used for measurements; however this 
deviates slightly from the perfect cylinder assumption which may influence the calculated flows. 
Additionally, finding the middle “layer” of the three-dimensional vessel to capture images of 
passing microspheres can be somewhat challenging; however, this step is important for optimal 
measurements and will be more intuitive with investigator practice.  
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Future Work 
Protocol development was performed on un-operated mice, which did not undergo any 
surgical modification to induce chronic ischemia. However with the establishment of the PIV 
protocol, this technique can now be applied to mice modeling chronic ischemia, femoral artery 
ligation; in combination with a murine hindlimb ischemia model, the PIV protocol allows 
investigators to determine how blood flow control is impacted by vascular remodeling in 
collateral arteries.  
An additional interest of implementing the PIV protocol is using a different imaging 
modality, confocal or multiphoton microscopy, to assess flow in the midzone of the collateral 
circuit. Using confocal or multiphoton microscopy allows for imaging deeper into the tissue and 
eliminates an increasing amount of autofluorescence/background noise.  
To determine the potential effect of a femoral artery ligation on conducted vasodilation 
within the hindlimb, a variation on the current functional vasodilation protocol can be performed. 
Instead of stimulating the gracilis muscle, the gastrocnemius (calf) muscle can be stimulated and 
the potential dilation and change in blood flow can be observed in the profunda femoris. This 
variation on the current protocol, if efficacious, adds insight into another aspect of chronic 
ischemia that has not been as extensively studied.  
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APPENDIX 
 
Particle Image Velocimetry Setup  
  
Instruments and equipment used for protocol development.  
 
 
 
Electrode placement on the gracilis muscle for functional vasodilation of profunda 
femoris artery. 
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Imaging and Data Analysis 
 
 It should be noted that during imaging the images were binned (4x4), i.e. ¼ of the pixels 
in a region were used, as a means to enhance the resolution. 
 For image analysis the line tool in ImageJ was used to measure the diameter of the 
profunda femoris, from edge to edge, five measurements were made along the length of the 
vessel and an average of these five values were taken to obtain an average diameter. In order to 
measure streak length, the line tool was again used to measure from the tip of the sphere to the 
tail of the sphere. In order to preserve the integrity of the data, microspheres were only measured 
if they appeared in the middle of the vessel, since flow is most consisted in the middle of the 
vessel. A demonstration of measurements can be viewed below. During data analysis the size of 
the microsphere was accounted for by subtracting 3.1 µm from the measured streak length.  
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Particle Image Velocimetry Protocol 
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